文献速递产科母胎医学

三胎妊娠减为双胎与减为单胎的胎儿存活率及妊娠结局比较:一项Meta分析

Fetal reduction of triplet pregnancies to twins vs singletons: a meta-analysis of survival and pregnancy outcome.
PubMed 文献 · Am J Obstet Gynecol · 2022-03-26

该系统综述与Meta分析比较三胎妊娠减为双胎与减为单胎后的胎儿存活率及围产结局,共纳入10项研究、2543例减胎的三胎妊娠(减为双胎2035例,减为单胎508例)。减为双胎者的胎儿存活率较低(OR 0.61,95%CI 0.40-0.92,P=.02),分娩孕周更早(均数差 -2.20周,95%CI -2.80至-1.61,P<.001),出生体重更低,<32周和<34周早产风险更高;早期妊娠丢失和新生儿死亡两组无显著差异。

要点

  • 减为双胎的胎儿存活率低于减为单胎(OR 0.61,95%CI 0.40-0.92,P=.02)。
  • 减为双胎的分娩孕周更早(均数差 -2.20周,95%CI -2.80至-1.61,P<.001)。
  • 减为双胎的出生体重更低,<32周和<34周早产风险更高。

核心结论

  • 三胎妊娠减为双胎者,全部剩余胎儿的存活率低于减为单胎者,分娩孕周更早、早产风险更高、出生体重更低。
  • 减为双胎与减为单胎在早期妊娠丢失率和新生儿死亡率上无实质差异。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Web of Science、Scopus和Embase自建库至2022年1月16日。
  • 纳入比较减为双胎与减为单胎的存活及围产结局的研究,共10项研究、2543例减胎的三胎妊娠。
  • 减为双胎2035例,减为单胎508例。
  • 采用随机效应模型合并均数差或比值比及95%置信区间,对超过3项研究报告的结局计算95%预测区间。

主要发现

  • 减为双胎的胎儿存活率低于减为单胎(OR 0.61,95%CI 0.40-0.92,P=.02;95%预测区间 0.36-1.03)。
  • 减为双胎与减为单胎的早期妊娠丢失率(OR 0.89,95%CI 0.58-1.38,P=.61;95%预测区间 0.54-1.48)和新生儿死亡率(OR 0.57,95%CI 0.09-3.50,P=.55)无显著差异。
  • 减为双胎的分娩孕周显著低于减为单胎(均数差 -2.20周,95%CI -2.80至-1.61,P<.001;95%预测区间 -4.27至-0.14)。
  • 减为双胎与更低的出生体重及更高的<32周和<34周早产风险相关。

关键数值与推荐

  • 主要结局为胎儿存活,定义为妊娠>24周的活产。
  • 次要结局包括分娩孕周、<32周和<34周早产、早期妊娠丢失(<24周)、低出生体重及新生儿死亡(出生后28天内)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This systematic review and meta-analysis aimed to compare the fetal survival rate and perinatal outcomes of triplet pregnancies after selective reduction to twin pregnancies vs singleton pregnancies. DATA SOURCES: PubMed, Web of Science, Scopus, and Embase were systematically searched from the inception of the databases to January 16, 2022. STUDY ELIGIBILITY CRITERIA: Studies comparing the survival and perinatal outcomes between reduction to twin pregnancies and reduction to singleton pregnancies were included. The primary outcomes were fetal survival, defined as a live birth at >24 weeks of gestation. The secondary outcomes were gestational age at birth, preterm birth at <32 and <34 weeks of gestation, early pregnancy loss (<24 weeks of gestation), low birthweight, and rate of neonatal demise (up to 28 days after birth). METHODS: The random-effect model was used to pool the mean differences or odds ratios and the corresponding 95% confidence intervals. To provide a range of expected effects if a new study was conducted, 95% prediction intervals were calculated for outcomes presented in >3 studies. RESULTS: Of note, 10 studies with 2543 triplet pregnancies undergoing fetal reduction, of which 2035 reduced to twin pregnancies and 508 reduced to singleton pregnancies, met the inclusion criteria. Reduction to twin pregnancies had a lower rate of fetal survival (odds ratio, 0.61; 95% confidence interval, 0.40-0.92; P=.02; 95% prediction interval, 0.36-1.03) and comparable rates of early pregnancy loss (odds ratio, 0.89; 95% confidence interval, 0.58-1.38; P=.61; 95% prediction interval, 0.54-1.48) and neonatal demise (odds ratio, 0.57; 95% confidence interval, 0.09-3.50; P=.55) than reduction to singleton pregnancies. Reduction to twin pregnancies had a significantly lower gestation age at birth (weeks) (mean difference, -2.20; 95% confidence interval, -2.80 to -1.61; P<.001; 95% prediction interval, -4.27 to -0.14) than reduction to singleton pregnancies. Furthermore, reduction to twin pregnancies was associated with lower birthweight and greater risk of preterm birth at <32 and <34 weeks of gestation. CONCLUSION: Triplet pregnancies reduced to twin pregnancies had a lower fetal survival rate of all remaining fetuses, lower gestational age at birth, higher risk of preterm birth, and lower birthweight than triplet pregnancies reduced to singleton pregnancies; reduction to twin pregnancies vs reduction to singleton pregnancies showed no substantial difference for the rates of early pregnancy loss and neonatal death.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hessami K, Evans MI, Nassr AA, et al. Fetal reduction of triplet pregnancies to twins vs singletons: a meta-analysis of survival and pregnancy outcome. Am J Obstet Gynecol. 2022. PMID: 35351408. doi:10.1016/j.ajog.2022.03.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。